Dr. Tony Farid Abdo, MD

Dr. Abdo practices at Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma.

Dr. Abdo's NPI, 1841555935, was assigned on July 5, 2012. Dr. Abdo graduated from Lebanese University School of Medicine in 2010. Dr. Abdo holds Oklahoma license 31330.

Dr. Abdo's primary practice is Ou Medical Center-the Children's Ho - Rad CT - HOPD, at 1200 Childrens Ave, Oklahoma City, OK 73104.

Dr. Abdo's primary practice is Ou Medical Center-The Children's Ho - Rad CT - HOPD in Oklahoma City, Oklahoma. Dr. Abdo is also affiliated with OU Health University of Oklahoma Medical Center. The medical group on file is OU Health. Dmand AI also links Dr. Abdo to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abdo practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Abdo's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Abdo is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Abdo's licenses on file in 3 states: Oklahoma, Rhode Island and Massachusetts.

Dmand AI lists acute respiratory failure, asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and sleep apnea among the conditions Dr. Abdo treats.

CMS data shows 397 Medicare services from Dr. Abdo across 11 procedure codes in 2024, for 160 Medicare patients. Medicare paid $37,827 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 160 Medicare patients who saw Dr. Abdo in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abdo's median patient age at 70, with 64% women.

In 2024, Dr. Abdo wrote 284 Medicare Part D claims for 35 patients. 43% of them were for generic drugs. CMS names the drug for 218 of them, across 9 drugs with 11 or more claims each, at $51,400 in total drug cost. In 2023, CMS named 195 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Abdo for performance year 2024, reported as part of a group. Dr. Abdo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 17 papers to Dr. Abdo, published from 2019 to 2024. 2022 was the busiest year, with 4. Dr. Abdo has published most often in Diagnostics (Basel). Dr. Abdo's most frequent co-authors are Jean I. Keddissi, MD, Awais Bajwa, MD and Nazir Ahmad, MBBS, MD.

Dmand AI links Dr. Abdo to 1 clinical trial. Conditions studied include Respiratory Distress Syndrome and Respiration Disorders.

CMS Open Payments shows 273 general payments to Dr. Abdo from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Fisher & Paykel Healthcare Limited paid the most, $1,260.

Dr. Abdo graduated from Lebanese University School of Medicine in 2010. Dr. Abdo is a member of ACCP, ATS and SCCM.

Dr. Abdo is in network with 13 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.